| Literature DB >> 30135937 |
Margabandhu Gopi1, Arambakkam Janardhanam Vanisree1.
Abstract
Parkinson's disease (PD), a progressive neurodegeneration, is characterized by loss of dopaminergic neurons in the substantia nigra (SN) and loss of motor co-ordination. Impaired metabolism of major lipids such as phospholipids which play regulatory roles in cellular functions and signaling has been implicated in the pathology of PD. We aim to investigate the striatal phospholipids (PLs) in hemiparkinsonism infused by rotenone in rats. As there are no cost-effective modes of PL, we have utilized dye-lipid complex technique for the first time in PD models for screening and also for semi-quantifying (individually) the levels of the deregulated PL in brain samples. Rats were divided into 2 groups: i. control and ii. ROT-infused which received intracranial injection of Rotenone (6 μg/μl; flow rate 0.2 μl/min). At the end of experimental period of 14 days, the striatum was dissected out for the analyses of PLs. Dye-based detection of PL and two-dimensional thin-layer chromatographic analyses of PL were performed. Detection of dye-PL complex was possible for phosphatidyl choline (PC), phosphatidyl inositol (PI), and spingomyelin (SM) (but not for phosphatidyl ethanolamine-PE) using dyes viz victoria blue B, toluidine blue and ammonium ferrothiocyanate, respectively. Two-dimensional analyses of phospholipids confirmed the dye-PL complex and depicted significant reduction (p < 0.05) on semi-quantitative assessment, in the striatum of control and hemiparkinsonic rats. We suggest a low level of PLs esp of PI in striatum of rats using a simple dye-detection that was validated by HR-LCMS. The finding implies that a critical role is being played by these PLs (PC, PI and SM) mainly PI (p < 0.001), in rotenone infused hemiparkinsonism, thus deserving wider but simpler investigations to detect and identify their role in parkinsonism.Entities:
Keywords: AD, Alzheimer's disease; AFTC, Ammonium ferrothiocyanate; ANSA, 1 Amino-2 naphthol-4 sulfonic acid; DA, Dopaminergic neuron; DMSO, Dimethyl sulfoxide; Dye-lipid complex; ESI, Electrospray ionization; HCl, Hydrochloric acid; HRLCMS, High resolution liquid chromatography–mass spectrometry; MRM, Multiple reaction monitor; MS, Mass spectrometry; NM, Neuromelanin; Na.EDTA, Sodium Ethylenediaminetetraacetic acid; NaCl, Sodium chloride; PC, Phosphatidyl choline; PD, Parkinson's disease; PE, Phosphatidyl ethanolamine; PI(3,5)P2, Phosphatidylinositol 3,5-bisphosphate; PI, Phosphoinositide; PLs, Phospholipids; Parkinson's disease; Phospholipids; PtdIns(3,4,5)P3, Phosphatidylinositol 3,4,5-trisphosphate; PtdIns(4,5)P2, Phosphatidylinositol 4,5-bisphosphate; PtdIns5P, Phosphatidylinositol 5-phosphate; ROT, Rotenone; Rotenone; SM, Spingomyelin; SNpc, Substantia nigra pars compacta; Striatum; TB, Toluidine blue dye; TBAHS, tetrabutyl ammonium hydrogen sulphate; TEM, Transmission electron microscopy; TLC, Thin layer chromatography; VBB, Victoria blue-B dye
Year: 2017 PMID: 30135937 PMCID: PMC6084873 DOI: 10.1016/j.ibror.2017.06.001
Source DB: PubMed Journal: IBRO Rep ISSN: 2451-8301
Fig. 1Hematoxylin and eosin (H and E) staining of striatum (A) Sections from control animals show normal histology in the striatum with round to oval shaped cells (B) ROT-infused rat sections reveal abnormal striatal histology with hyperstained irregularly shaped cells along with vacuolation of neurophil as well as microcyst of neurophils and swelling of neurons. Sections stained with hematoxylin and eosin ×400. (indicated by arrows).
Fig. 2Transmission electron microscopy micrographs of the striatum (n = 6) representing the ultrastructure of nuclei, mitochondria, Synaptic vesicles and Lipid droplets. (A) Striatal sections of control depict intact structures. (white arrows, ×10,000 magnification) and (B) ROT-infused rats depict the shrunken nuclei and condensed chromatin. The mitochondria were noticeably swollen and vacuolated cristae and also decreased number of synaptic vesicles along with inflammation of lipid droplets (white arrows, ×30,000 magnification) as compared to control.
Fig. 3Separation of phospholipids in Two-dimensional TLC and semi-quantification by inorganic phosphorous estimation in control and ROT-infused rats. [c,i,s control, infused (rotenone) and standard respectively]. Values were expressed as mean ± SEM (n = 6). Each samples were repeated thrice, ***p < 0.001, **p < 0.01 (ROT-infused Vs Control) *p < 0.05 and NS-Non significant (Control Vs Standard).
Rf values as obtained two-dimensional TLC of individual phospholipids of standard, control and samples hemiparkinsonism.
| Standards | Rf values | ||
|---|---|---|---|
| Standard | Control | ROT-Infused | |
| Phosphatidyl choline | 0.41 | 0.40 | 0.40 |
| Phosphatidyl ethanolamine | 0.84 | 0.84 | 0.83 |
| Phosphatidyl inositol | 0.61 | 0.60 | 0.60 |
| Spingomyelin | 0.37 | 0.36 | 0.36 |
Fig. 4Fluorescence Spectroscopic of Dye-PLs and their complex with PC, PI and SM. Fluorescence excitation and emission spectra (λ ex/λ em) of dyes and their complexes with PL: VBB-375/390 nm; VBB + PC-375/393 nm; TB-370/395 nm; TB + PI-375/400 nm; AFTC-395/400 nm; AFTC + SM-392/396 nm.
Fig. 5HR-LCMS separation of phosphoinositides – PI(3,5)P in control and ROT-infused rats. Values were expressed as mean ± SEM (n = 6). Each samples were repeated thrice, ***p < 0.001 (ROT-infused Vs Control) **p < 0.01(Control Vs Standard).